Preview Mode Links will not work in preview mode

Clinical Literature Summaries presented by InpharmD™ (S4))

Nov 10, 2021

A randomized, adaptive, platform trial conducted to assess the efficacy of fluvoxamine versus placebo in preventing hospitalization (defined as either retention in a COVID-19 emergency setting or transfer to a tertiary hospital due to COVID-19).